David Ross Smith Insider Trading for March 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for David Ross Smith.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of David Ross Smith for March 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 88.36 | 100 | 8,836 | 13,495 | 13.6 K to 13.5 K (-0.74 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 88.33 | 100 | 8,833 | 13,595 | 13.7 K to 13.6 K (-0.73 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 88.27 | 200 | 17,654 | 13,695 | 13.9 K to 13.7 K (-1.44 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 88.25 | 100 | 8,825 | 13,895 | 14 K to 13.9 K (-0.71 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 88.22 | 100 | 8,822 | 13,995 | 14.1 K to 14 K (-0.71 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 88.20 | 300 | 26,460 | 14,095 | 14.4 K to 14.1 K (-2.08 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 88.18 | 90 | 7,936 | 14,395 | 14.5 K to 14.4 K (-0.62 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 88.16 | 200 | 17,632 | 14,485 | 14.7 K to 14.5 K (-1.36 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 88.15 | 100 | 8,815 | 14,685 | 14.8 K to 14.7 K (-0.68 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 88.14 | 100 | 8,814 | 14,785 | 14.9 K to 14.8 K (-0.67 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 88.13 | 200 | 17,626 | 14,885 | 15.1 K to 14.9 K (-1.33 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 88.12 | 20 | 1,762 | 15,085 | 15.1 K to 15.1 K (-0.13 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 88.11 | 280 | 24,671 | 15,105 | 15.4 K to 15.1 K (-1.82 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 88.10 | 100 | 8,810 | 15,385 | 15.5 K to 15.4 K (-0.65 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 88.08 | 300 | 26,424 | 15,485 | 15.8 K to 15.5 K (-1.90 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 88.07 | 300 | 26,421 | 15,785 | 16.1 K to 15.8 K (-1.87 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 88.06 | 200 | 17,612 | 16,085 | 16.3 K to 16.1 K (-1.23 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 88.05 | 800 | 70,440 | 16,285 | 17.1 K to 16.3 K (-4.68 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 88.04 | 300 | 26,412 | 17,085 | 17.4 K to 17.1 K (-1.73 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Option Exercise | M | 73.70 | 4,187 | 308,582 | 12,562 | |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Option Exercise | M | 76.12 | 1,248 | 94,998 | 3,747 | |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Option Exercise | M | 76.67 | 4,315 | 330,831 | 4,316 | |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Option Exercise | M | 51.45 | 1,890 | 97,241 | 18,707 | |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 88.03 | 567 | 49,913 | 17,385 | 18 K to 17.4 K (-3.16 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 88.02 | 600 | 52,812 | 17,952 | 18.6 K to 18 K (-3.23 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 88.01 | 500 | 44,005 | 18,552 | 19.1 K to 18.6 K (-2.62 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 88.00 | 300 | 26,400 | 19,052 | 19.4 K to 19.1 K (-1.55 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 87.99 | 1,172 | 103,124 | 19,352 | 20.5 K to 19.4 K (-5.71 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 87.98 | 500 | 43,990 | 20,524 | 21 K to 20.5 K (-2.38 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 87.98 | 100 | 8,798 | 21,024 | 21.1 K to 21 K (-0.47 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 87.97 | 900 | 79,173 | 21,124 | 22 K to 21.1 K (-4.09 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 87.97 | 100 | 8,797 | 22,024 | 22.1 K to 22 K (-0.45 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 87.96 | 300 | 26,388 | 22,124 | 22.4 K to 22.1 K (-1.34 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 87.95 | 100 | 8,795 | 22,424 | 22.5 K to 22.4 K (-0.44 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 87.95 | 200 | 17,589 | 22,524 | 22.7 K to 22.5 K (-0.88 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 87.94 | 100 | 8,794 | 22,724 | 22.8 K to 22.7 K (-0.44 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 87.92 | 100 | 8,792 | 22,824 | 22.9 K to 22.8 K (-0.44 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 87.90 | 100 | 8,790 | 22,924 | 23 K to 22.9 K (-0.43 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 87.88 | 100 | 8,788 | 23,024 | 23.1 K to 23 K (-0.43 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 87.87 | 100 | 8,787 | 23,124 | 23.2 K to 23.1 K (-0.43 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 87.86 | 200 | 17,572 | 23,224 | 23.4 K to 23.2 K (-0.85 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 87.85 | 111 | 9,751 | 23,424 | 23.5 K to 23.4 K (-0.47 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 87.84 | 100 | 8,784 | 23,535 | 23.6 K to 23.5 K (-0.42 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 87.82 | 500 | 43,910 | 23,635 | 24.1 K to 23.6 K (-2.07 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 87.81 | 300 | 26,343 | 24,135 | 24.4 K to 24.1 K (-1.23 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 87.80 | 200 | 17,560 | 24,435 | 24.6 K to 24.4 K (-0.81 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 87.78 | 100 | 8,778 | 24,635 | 24.7 K to 24.6 K (-0.40 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 87.76 | 200 | 17,552 | 24,735 | 24.9 K to 24.7 K (-0.80 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Sell | S | 87.73 | 200 | 17,546 | 24,935 | 25.1 K to 24.9 K (-0.80 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Buy | M | 73.70 | 4,187 | 308,582 | 25,135 | 20.9 K to 25.1 K (+19.99 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Buy | M | 76.12 | 1,248 | 94,998 | 20,948 | 19.7 K to 20.9 K (+6.34 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Buy | M | 76.67 | 4,315 | 330,831 | 19,700 | 15.4 K to 19.7 K (+28.05 %) |
| Mar 07 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Buy | M | 51.45 | 1,890 | 97,241 | 15,385 | 13.5 K to 15.4 K (+14.01 %) |
| Mar 01 2017 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate EVP, CFO ... | Payment of Exercise | F | 88.05 | 159 | 14,000 | 13,495 | 13.7 K to 13.5 K (-1.16 %) |